Adaptive Biotechnologies Corp Financial Ratios
ADPT / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-27.2%
Profit Margin
-21.5%
Net Income / Revenue
Asset Turnover
0.54
Revenue / Total Assets
Equity Multiplier
2.34
Total Assets / Equity
Composite: -27.2% (reported: -27.2%)
Profitability
Liquidity
Current Ratio
3.34
Quick Ratio
3.23
Solvency
Interest Coverage
-3.90
Efficiency
Asset Turnover
0.54
Inventory Turnover
7.27
Days Sales Outstanding
66 days
As of FY2025 · SEC 10-K · Updated Jul 1, 2026
Earnings Quality
Accrual Ratio
-2.6%
+9.3pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.